Evaluation of several serum interleukins as markers for treatment effectiveness in naïve HIV infected patients: A pilot study

1Citations
Citations of this article
39Readers
Mendeley users who have this article in their library.

Abstract

In this observational pilot study, we investigated the impact of Dolutegravir, Raltegravir, Elvitegravir (Integrase Strand Transfer Inhibitors, INSTIs), or boosted Darunavir (a Protease Inhibitor, PI) in combination with two nucleoside reverstranscriptase inhibitors (Emtricitabine/Tenofovir disoproxil or Lamivudine/Tenofovir disoproxil, NRTI) on four interleukins (IL-4, IL-10, IL-13, and IL-21) as immune activation markers in naïve HIV(Human Immunodeficiency Virus)-infected patients during the first six months of combined standard-of-care antiretroviral therapy (cART). Newly diagnosed with HIV-infected subjects and without any disease that could affect the immune activation markers were evaluated. The patients’ physicians recommended the cART as standard-of-care and the ILs were measured before cART and six months of cART. The levels of CD4+ T-cells count and CD4+/CD8+ ratio significantly increased at six months (P-value<0.02) regardless of the drugs, INSTIs or PI. However, a CD4+/CD8+ >1 was observed in 25% of patients treated with Raltegravir and half of those treated with Dolutegravir. At six months of cART, viral load was detectable in only 6/ 31 individuals. IL-21 had an undetectable level in 30/31 patients after six months of cART. Our results suggest the potency in restoring immune markers in HIV-infected patients with all investigated drugs. Dolutegravir showed a tendency to statistically significant changes in IL-4 and IL-10. A clinical trial with random allocation of medication and an extensive followup is needed to replicate this research and validate the usefulness of evaluated ILs as markers of cART effectiveness.

References Powered by Scopus

Inflammatory and coagulation biomarkers and mortality in patients with HIV infection

1366Citations
N/AReaders
Get full text

CD8 T Cell Exhaustion During Chronic Viral Infection and Cancer

1232Citations
N/AReaders
Get full text

Markers of inflammation, coagulation, and renal function are elevated in adults with HIV infection

694Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Dupilumab for the treatment of atopic dermatitis comorbid with human immunodeficiency virus infection: a case report

0Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Jianu, C., Itu-Mureşan, C., Drugan, C., Filipescu, I., Topan, A. V., Jianu, M. E., … Bolboacă, S. D. (2021). Evaluation of several serum interleukins as markers for treatment effectiveness in naïve HIV infected patients: A pilot study. PLoS ONE, 16(November). https://doi.org/10.1371/journal.pone.0260007

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 4

67%

Researcher 2

33%

Readers' Discipline

Tooltip

Medicine and Dentistry 8

73%

Biochemistry, Genetics and Molecular Bi... 1

9%

Nursing and Health Professions 1

9%

Immunology and Microbiology 1

9%

Article Metrics

Tooltip
Social Media
Shares, Likes & Comments: 32

Save time finding and organizing research with Mendeley

Sign up for free